NCT07309276 2025-12-30
A Phase II Clinical Study Evaluating the Combination Therapy of JS212 in Patients With Advanced Lung Cancer
Shanghai Junshi Bioscience Co., Ltd.
Phase 2 Not yet recruiting
Shanghai Junshi Bioscience Co., Ltd.
Shanghai Chest Hospital
Mabwell (Shanghai) Bioscience Co., Ltd.